{"id":45829,"date":"2022-07-05T18:01:56","date_gmt":"2022-07-05T16:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/"},"modified":"2022-07-05T18:01:56","modified_gmt":"2022-07-05T16:01:56","slug":"molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/","title":{"rendered":"Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5312233\/molecular-diagnostics-for-cancer-markets?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=kc874r&amp;utm_campaign=1722061+-+Molecular+Diagnostics+for+Cancer+Market+Report+2022%3A+Companion+Diagnostics+and+Liquid+Biopsy+Drive+Market+Growth+while+Lowering+Costs&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive &amp; Consultant Guides and Customization&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220705005636\/en\/1504795\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220705005636\/en\/1504795\/21\/logo.jpg\"><\/a><\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Molecular Dx Oncology Market &#8211; Strategic Situation Analysis with Impact of the COVID-19 Pandemic<\/strong>\n<\/p>\n<p>\n<strong>2 Guide for Executives, Marketing, Sales and Business Development Staff<\/strong>\n<\/p>\n<p>\n<strong>3 Guide for Management Consultants and Investment Advisors<\/strong>\n<\/p>\n<p>\n<strong>4 Introduction and Market Definition<\/strong>\n<\/p>\n<p>\n<strong>5 Market Overview<\/strong>\n<\/p>\n<p>\n5.1 Market Participants\n<\/p>\n<p>\n5.1.1 Academic Research Lab\n<\/p>\n<p>\n5.1.2 Diagnostic Test Developer\n<\/p>\n<p>\n5.1.3 Genomic Instrumentation Supplier\n<\/p>\n<p>\n5.1.4 Cell Separation and Viewing Instrumentation Supplier.\n<\/p>\n<p>\n5.1.5 Pharmaceutical\/Reagent Supplier\n<\/p>\n<p>\n5.1.6 Independent Testing Lab\n<\/p>\n<p>\n5.1.7 Public National\/Regional Lab\n<\/p>\n<p>\n5.1.8 Hospital lab\n<\/p>\n<p>\n5.1.9 Physician Lab\n<\/p>\n<p>\n5.1.10 Audit Bodies\n<\/p>\n<p>\n5.1.11 Certification Body\n<\/p>\n<p>\n5.2 Market Segments\n<\/p>\n<p>\n5.2.1 Traditional Market Segmentation\n<\/p>\n<p>\n5.2.2 Laboratory Focus and Segmentation\n<\/p>\n<p>\n5.3 Industry Structure\n<\/p>\n<p>\n5.3.1 Hospital Testing Share\n<\/p>\n<p>\n5.3.2 Economies of Scale\n<\/p>\n<p>\n5.3.3 Physician Office Labs\n<\/p>\n<p>\n5.3.4 Physicians and POCT\n<\/p>\n<p>\n<strong>6 Market Trends<\/strong>\n<\/p>\n<p>\n6.1 Factors Driving Growth\n<\/p>\n<p>\n6.1.1 New Diagnostics Create New Markets\n<\/p>\n<p>\n6.1.2 New Roles for Diagnostics\n<\/p>\n<p>\n6.1.3 Longevity and Outcomes\n<\/p>\n<p>\n6.1.4 Expanding the Pharmaceutical Toolbox\n<\/p>\n<p>\n6.1.5 Regulatory Retreat\n<\/p>\n<p>\n6.2 Factors Limiting Growth\n<\/p>\n<p>\n6.2.1 Falling Prices\n<\/p>\n<p>\n6.2.2 Lower Costs\n<\/p>\n<p>\n6.2.3 COVID Pandemic\n<\/p>\n<p>\n6.2.4 Wellness has a Downside\n<\/p>\n<p>\n6.3 Instrumentation and Automation\n<\/p>\n<p>\n6.3.1 Instruments Key to Market Share\n<\/p>\n<p>\n6.3.2 Bioinformatics Plays a Role\n<\/p>\n<p>\n6.4 Diagnostic Technology Development\n<\/p>\n<p>\n6.4.1 Next Generation Sequencing\n<\/p>\n<p>\n6.4.2 Shifting Role of Diagnostics\n<\/p>\n<p>\n6.4.3 Multiplexing and Foundation One\n<\/p>\n<p>\n6.4.4 Pharmacogenomics Technology\n<\/p>\n<p>\n6.4.5 Whole Genome Sequencing\n<\/p>\n<p>\n6.4.6 Gene Editing and Gene Therapy\n<\/p>\n<p>\n<strong>7 Molecular Diagnostics Recent Developments<\/strong>\n<\/p>\n<p>\n<strong>8 Profiles of Key MDx Companies<\/strong>\n<\/p>\n<p>\n<strong>9 The Global Market for MDx Cancer<\/strong>\n<\/p>\n<p>\n9.1 MDx Cancer &#8211; Global Market Overview by Country\n<\/p>\n<p>\n9.2 Global Market by Cancer Type &#8211; Overview\n<\/p>\n<p>\n9.3 Global Market by Product Type &#8211; Overview\n<\/p>\n<p>\n9.4 Global Market by Place &#8211; Overview\n<\/p>\n<p>\n<strong>10. Global Market by Cancer Type<\/strong>\n<\/p>\n<p>\n10.1 MDx Breast Cancer\n<\/p>\n<p>\n10.2 MDx Colorectal Cancer\n<\/p>\n<p>\n10.3 MDx Cervical Cancer\n<\/p>\n<p>\n10.4 MDx Lung Cancer\n<\/p>\n<p>\n10.5 MDx Prostate\n<\/p>\n<p>\n10.6 MDx Melanoma Cancer\n<\/p>\n<p>\n10.7 MDx Blood\n<\/p>\n<p>\n10.8 MDx Companion Dx Development\n<\/p>\n<p>\n10.9 MDx Other Cancer\n<\/p>\n<p>\n<strong>11. Global Market by Product Type<\/strong>\n<\/p>\n<p>\n11.1 MDx Instruments\n<\/p>\n<p>\n11.2 MDx Reagents\n<\/p>\n<p>\n11.3 MDx Software and Services\n<\/p>\n<p>\n<strong>12. Global Market by Place<\/strong>\n<\/p>\n<p>\n12.1 MDx Clinical Laboratory\n<\/p>\n<p>\n12.2 MDx Pharmaceutical\n<\/p>\n<p>\n12.3 MDx Research\n<\/p>\n<p>\n<strong>13 Cancer Treatment and Trials<\/strong>\n<\/p>\n<p>\n13.1 FDA Cancer Drug Approvals by Year\n<\/p>\n<p>\n13.2 Clinical Trials Started 2010 to 2016\n<\/p>\n<p>\n13.3 Prevalence of Cancer Treatments &#8211; 2015\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\n10x Genomics, Inc.\n<\/li>\n<li>\nAbbott Diagnostics\n<\/li>\n<li>\nAccuraGen Inc.\n<\/li>\n<li>\nAdaptive Biotechnologies\n<\/li>\n<li>\nAethlon Medical\n<\/li>\n<li>\nAgena Bioscience, Inc.\n<\/li>\n<li>\nAgilent\n<\/li>\n<li>\nAnchor Dx\n<\/li>\n<li>\nANGLE plc\n<\/li>\n<li>\nApoCell, Inc.\n<\/li>\n<li>\nArcherDx, Inc.\n<\/li>\n<li>\nARUP Laboratories\n<\/li>\n<li>\nAsuragen\n<\/li>\n<li>\nAVIVA Biosciences\n<\/li>\n<li>\nBaylor Miraca Genetics Laboratories\n<\/li>\n<li>\nBeckman Coulter, Inc.\n<\/li>\n<li>\nBGI Genomics Co. Ltd.\n<\/li>\n<li>\nBio-Rad Laboratories, Inc.\n<\/li>\n<li>\nBio-Reference Laboratories\n<\/li>\n<li>\nBio-Techne\n<\/li>\n<li>\nBioarray Genetics\n<\/li>\n<li>\nBiocartis\n<\/li>\n<li>\nBiocept, Inc.\n<\/li>\n<li>\nBiodesix Inc.\n<\/li>\n<li>\nBioFluidica\n<\/li>\n<li>\nBioGenex\n<\/li>\n<li>\nBiolidics Ltd.\n<\/li>\n<li>\nbioMerieux Diagnostics\n<\/li>\n<li>\nBioneer Corporation\n<\/li>\n<li>\nBioview\n<\/li>\n<li>\nBolidics\n<\/li>\n<li>\nBoreal Genomics\n<\/li>\n<li>\nBristol-Myers Squibb\n<\/li>\n<li>\nCancer Genetics\n<\/li>\n<li>\nCaris Molecular Diagnostics\n<\/li>\n<li>\nCellMax Life\n<\/li>\n<li>\nCepheid (now Danaher)\n<\/li>\n<li>\nCharles River Laboratories\n<\/li>\n<li>\nChronix Biomedical\n<\/li>\n<li>\nCirculogene\n<\/li>\n<li>\nClinical Genomics\n<\/li>\n<li>\nCynvenio\n<\/li>\n<li>\nCytolumina Technologies Corp.\n<\/li>\n<li>\nCytoTrack\n<\/li>\n<li>\nDatar Cancer Genetics Limited\n<\/li>\n<li>\nDiagnologix LLC\n<\/li>\n<li>\nDiasorin S.p.A.\n<\/li>\n<li>\nEnzo Life Sciences, Inc.\n<\/li>\n<li>\nEpic Sciences\n<\/li>\n<li>\nEpigenomics AG\n<\/li>\n<li>\nEurofins Scientific\n<\/li>\n<li>\nExosome Diagnostics\n<\/li>\n<li>\nExosome Sciences\n<\/li>\n<li>\nFabric Genomics\n<\/li>\n<li>\nFluidigm Corp\n<\/li>\n<li>\nFluxion Biosciences\n<\/li>\n<li>\nFoundation Medicine\n<\/li>\n<li>\nFreenome\n<\/li>\n<li>\nFUJIFILM Wako Diagnostics\n<\/li>\n<li>\nGeneFirst Ltd.\n<\/li>\n<li>\nGenetron Health (Beijing) Co. Ltd.\n<\/li>\n<li>\nGenomic Health\n<\/li>\n<li>\nGenomOncology\n<\/li>\n<li>\nGILUPI Nanomedizin\n<\/li>\n<li>\nGrail, Inc.\n<\/li>\n<li>\nGuardant Health\n<\/li>\n<li>\nHalioDx\n<\/li>\n<li>\nHansaBiomed\n<\/li>\n<li>\nHeiScreen\n<\/li>\n<li>\nHelomics\n<\/li>\n<li>\nHorizon Discovery\n<\/li>\n<li>\nHTG Molecular Diagnostics\n<\/li>\n<li>\niCellate\n<\/li>\n<li>\nIllumina\n<\/li>\n<li>\nIncell Dx\n<\/li>\n<li>\nInivata\n<\/li>\n<li>\nIntegrated Diagnostics\n<\/li>\n<li>\nInvivogen\n<\/li>\n<li>\nInvivoscribe\n<\/li>\n<li>\nJanssen Diagnostics\n<\/li>\n<li>\nMDNA Life Sciences, Inc.\n<\/li>\n<li>\nMDx Health\n<\/li>\n<li>\nMenarini Silicon Biosystems\n<\/li>\n<li>\nMillipore Sigma\n<\/li>\n<li>\nMiltenyi Biotec\n<\/li>\n<li>\nMIODx\n<\/li>\n<li>\nmiR Scientific\n<\/li>\n<li>\nMolecular MD\n<\/li>\n<li>\nMyCartis\n<\/li>\n<li>\nMyriad Genetics\/Myriad RBM\n<\/li>\n<li>\nNantHealth, Inc.\n<\/li>\n<li>\nNatera\n<\/li>\n<li>\nNeoGenomics\n<\/li>\n<li>\nNew Oncology\n<\/li>\n<li>\nNovogene Bioinformatics Technology Co. Ltd.\n<\/li>\n<li>\nOncocyte\n<\/li>\n<li>\nOncoDNA\n<\/li>\n<li>\nOrtho Clinical Diagnostics\n<\/li>\n<li>\nOxford Nanopore Technologies\n<\/li>\n<li>\nPanagene\n<\/li>\n<li>\nPerkin Elmer\n<\/li>\n<li>\nPersonal Genome Diagnostics\n<\/li>\n<li>\nPersonalis\n<\/li>\n<li>\nPrecipio\n<\/li>\n<li>\nPrecisionMed\n<\/li>\n<li>\nPromega\n<\/li>\n<li>\nQiagen GmbH\n<\/li>\n<li>\nRarecells SAS\n<\/li>\n<li>\nRareCyte\n<\/li>\n<li>\nRoche Molecular Diagnostics\n<\/li>\n<li>\nScreencell\n<\/li>\n<li>\nSense Biodetection\n<\/li>\n<li>\nSerametrix\n<\/li>\n<li>\nSiemens Healthineers\n<\/li>\n<li>\nSilicon Biosystems\n<\/li>\n<li>\nSimfo GmbH\n<\/li>\n<li>\nSinglera Genomics Inc.\n<\/li>\n<li>\nSingulomics\n<\/li>\n<li>\nSkylineDx\n<\/li>\n<li>\nStratos Genomics\n<\/li>\n<li>\nSysmex Inostics\n<\/li>\n<li>\nTempus Labs, Inc.\n<\/li>\n<li>\nThermo Fisher Scientific Inc.\n<\/li>\n<li>\nThrive Earlier Detection\n<\/li>\n<li>\nTodos Medical\n<\/li>\n<li>\nTrovagene\n<\/li>\n<li>\nVolition\n<\/li>\n<li>\nVortex Biosciences\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5312233\/molecular-diagnostics-for-cancer-markets?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=kc874r&amp;utm_campaign=1722061+-+Molecular+Diagnostics+for+Cancer+Market+Report+2022%3A+Companion+Diagnostics+and+Liquid+Biopsy+Drive+Market+Growth+while+Lowering+Costs&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/aqhuvu<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x70;r&#101;&#115;&#x73;&#x40;r&#101;&#x73;&#x65;a&#114;&#x63;&#x68;a&#110;&#100;&#x6d;&#x61;r&#107;&#x65;&#x74;s&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;r&#x65;&#115;&#x73;&#64;r&#x65;s&#x65;&#97;&#x72;&#99;h&#x61;&#110;&#x64;&#109;a&#x72;k&#x65;&#116;&#x73;&#46;c&#x6f;m<\/a>\n<\/p>\n<p>\nFor E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive &amp; Consultant Guides and Customization&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Key Topics Covered: 1 Molecular Dx Oncology Market &#8211; Strategic Situation Analysis with Impact of the COVID-19 Pandemic 2 Guide for Executives, Marketing, Sales and Business Development &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45829","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive &amp; Consultant Guides and Customization&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Key Topics Covered: 1 Molecular Dx Oncology Market &#8211; Strategic Situation Analysis with Impact of the COVID-19 Pandemic 2 Guide for Executives, Marketing, Sales and Business Development ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-05T16:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220705005636\/en\/1504795\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-05T16:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/\"},\"wordCount\":648,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220705005636\\\/en\\\/1504795\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/\",\"name\":\"Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220705005636\\\/en\\\/1504795\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-05T16:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220705005636\\\/en\\\/1504795\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220705005636\\\/en\\\/1504795\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive &amp; Consultant Guides and Customization&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Key Topics Covered: 1 Molecular Dx Oncology Market &#8211; Strategic Situation Analysis with Impact of the COVID-19 Pandemic 2 Guide for Executives, Marketing, Sales and Business Development ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-05T16:01:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220705005636\/en\/1504795\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs &#8211; ResearchAndMarkets.com","datePublished":"2022-07-05T16:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/"},"wordCount":648,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220705005636\/en\/1504795\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/","name":"Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220705005636\/en\/1504795\/21\/logo.jpg","datePublished":"2022-07-05T16:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220705005636\/en\/1504795\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220705005636\/en\/1504795\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/molecular-diagnostics-for-cancer-market-report-2022-companion-diagnostics-and-liquid-biopsy-drive-market-growth-while-lowering-costs-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Molecular Diagnostics for Cancer Market Report 2022: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45829"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45829\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}